Evaluation of Weekly Tafenoquine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1997
This study is a phase 2b, placebo controlled, randomized, blinded study of the efficacy of WR 238605, a new primaquine analog, compared to placebo as chemosuppression of P. falciparum malaria in Nyanza Province, western Kenya.
Epistemonikos ID: 08d96501aa4c7e768257121caf5d47eda29c74d5
First added on: May 12, 2024